137 related articles for article (PubMed ID: 36989114)
1. MAIT cells activate dendritic cells to promote T
Pankhurst TE; Buick KH; Lange JL; Marshall AJ; Button KR; Palmer OR; Farrand KJ; Montgomerie I; Bird TW; Mason NC; Kuang J; Compton BJ; Comoletti D; Salio M; Cerundolo V; Quiñones-Mateu ME; Painter GF; Hermans IF; Connor LM
Cell Rep; 2023 Apr; 42(4):112310. PubMed ID: 36989114
[TBL] [Abstract][Full Text] [Related]
2. Targeting MAIT cells as a cellular adjuvant for humoral immunity: a new player in a very old game.
Provine NM
Immunol Cell Biol; 2023 Jul; 101(6):470-472. PubMed ID: 37137689
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 spike-FLIPr fusion protein plus lipidated FLIPr protects against various SARS-CoV-2 variants in hamsters.
Hsieh M-S; Hsu C-W; Liao H-C; Lin C-L; Chiang C-Y; Chen M-Y; Liu S-J; Liao C-L; Chen H-W
J Virol; 2024 Feb; 98(2):e0154623. PubMed ID: 38299865
[TBL] [Abstract][Full Text] [Related]
4. Oral Bacteria Combined with an Intranasal Vaccine Protect from Influenza A Virus and SARS-CoV-2 Infection.
Nagai M; Moriyama M; Ichinohe T
mBio; 2021 Aug; 12(4):e0159821. PubMed ID: 34399617
[TBL] [Abstract][Full Text] [Related]
5. An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal mice.
Khalil SM; Tonkin DR; Snead AT; Parks GD; Johnston RE; White LJ
J Virol; 2014 Aug; 88(16):9182-96. PubMed ID: 24899195
[TBL] [Abstract][Full Text] [Related]
6. A Bacteriophage-Based, Highly Efficacious, Needle- and Adjuvant-Free, Mucosal COVID-19 Vaccine.
Zhu J; Jain S; Sha J; Batra H; Ananthaswamy N; Kilgore PB; Hendrix EK; Hosakote YM; Wu X; Olano JP; Kayode A; Galindo CL; Banga S; Drelich A; Tat V; Tseng CK; Chopra AK; Rao VB
mBio; 2022 Aug; 13(4):e0182222. PubMed ID: 35900097
[TBL] [Abstract][Full Text] [Related]
7. PIKA provides an adjuvant effect to induce strong mucosal and systemic humoral immunity against SARS-CoV.
Gai WW; Zhang Y; Zhou DH; Chen YQ; Yang JY; Yan HM
Virol Sin; 2011 Apr; 26(2):81-94. PubMed ID: 21468931
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of elastase enhances the adjuvanticity of alum and promotes anti-SARS-CoV-2 systemic and mucosal immunity.
Kim E; Attia Z; Woodfint RM; Zeng C; Kim SH; Steiner HE; Shukla RK; Liyanage NPM; Ghimire S; Li J; Renukaradhya GJ; Satoskar AR; Amer AO; Liu SL; Cormet-Boyaka E; Boyaka PN
Proc Natl Acad Sci U S A; 2021 Aug; 118(34):. PubMed ID: 34353890
[TBL] [Abstract][Full Text] [Related]
9. Sex-biased immunogenicity of a mucosal subunit vaccine against SARS-CoV-2 in mice.
Li J; Hsu KS; Howe SE; Hoang T; Xia Z; Berzofsky JA; Sui Y
Front Immunol; 2024; 15():1386243. PubMed ID: 38835757
[TBL] [Abstract][Full Text] [Related]
10. Intranasal nanoemulsion adjuvanted S-2P vaccine demonstrates protection in hamsters and induces systemic, cell-mediated and mucosal immunity in mice.
Ganesan S; Acosta H; Brigolin C; Orange K; Trabbic K; Chen C; Lien CE; Lin YJ; Lin MY; Chuang YS; Fattom A; Bitko V
PLoS One; 2022; 17(11):e0272594. PubMed ID: 36322572
[TBL] [Abstract][Full Text] [Related]
11. Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice.
Lu B; Huang Y; Huang L; Li B; Zheng Z; Chen Z; Chen J; Hu Q; Wang H
Immunology; 2010 Jun; 130(2):254-61. PubMed ID: 20406307
[TBL] [Abstract][Full Text] [Related]
12. Intranasal delivery of an adenovirus-vector vaccine co-expressing a modified spike protein and a genetic adjuvant confers lasting mucosal immunity against SARS-CoV-2.
Jung HE; Ku KB; Kang BH; Park JH; Kim HC; Kim KD; Lee HK
Antiviral Res; 2023 Aug; 216():105656. PubMed ID: 37327877
[TBL] [Abstract][Full Text] [Related]
13. MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccine.
Boulouis C; Kammann T; Cuapio A; Parrot T; Gao Y; Mouchtaridi E; Wullimann D; Lange J; Chen P; Akber M; Rivera Ballesteros O; Muvva JR; ; Smith CIE; Vesterbacka J; Kieri O; Nowak P; Bergman P; Buggert M; Ljunggren HG; Aleman S; Sandberg JK
Mol Med; 2022 May; 28(1):54. PubMed ID: 35562666
[TBL] [Abstract][Full Text] [Related]
14. A-910823, a squalene-based emulsion adjuvant, induces T follicular helper cells and humoral immune responses
Yoshioka Y; Kobiyama K; Hayashi T; Onishi M; Yanagida Y; Nakagawa T; Hashimoto M; Nishinaka A; Hirose J; Asaoka Y; Tajiri M; Hayata A; Ishida S; Omoto S; Nagira M; Ishii KJ
Front Immunol; 2023; 14():1116238. PubMed ID: 36891311
[TBL] [Abstract][Full Text] [Related]
15. Intranasal administration of unadjuvanted SARS-CoV-2 spike antigen boosts antigen-specific immune responses induced by parenteral protein subunit vaccine prime in mice and hamsters.
Agbayani G; Akache B; Renner TM; Tran A; Stuible M; Dudani R; Harrison BA; Duque D; Bavananthasivam J; Deschatelets L; Hemraz UD; Régnier S; Durocher Y; McCluskie MJ
Eur J Immunol; 2024 Jun; 54(6):e2350620. PubMed ID: 38561974
[TBL] [Abstract][Full Text] [Related]
16. Measles Virus-Based Vaccine Expressing Membrane-Anchored Spike of SARS-CoV-2 Inducing Efficacious Systemic and Mucosal Humoral Immunity in Hamsters.
Yang ZH; Song YL; Pei J; Li SZ; Liu RL; Xiong Y; Wu J; Liu YL; Fan HF; Wu JH; Wang ZJ; Guo J; Meng SL; Chen XQ; Lu J; Shen S
Viruses; 2024 Apr; 16(4):. PubMed ID: 38675901
[TBL] [Abstract][Full Text] [Related]
17. Induction of systemic, mucosal, and cellular immunity against SARS-CoV-2 in mice vaccinated by trans-airway with a S1 protein combined with a pulmonary surfactant-derived adjuvant SF-10.
Kimoto T; Sakai S; Kameda K; Morita R; Takahashi E; Shinohara Y; Kido H
Influenza Other Respir Viruses; 2023 Mar; 17(3):e13119. PubMed ID: 36909295
[TBL] [Abstract][Full Text] [Related]
18. Targeting the MR1-MAIT cell axis improves vaccine efficacy and affords protection against viral pathogens.
Rashu R; Ninkov M; Wardell CM; Benoit JM; Wang NI; Meilleur CE; D'Agostino MR; Zhang A; Feng E; Saeedian N; Bell GI; Vahedi F; Hess DA; Barr SD; Troyer RM; Kang CY; Ashkar AA; Miller MS; Haeryfar SMM
PLoS Pathog; 2023 Jun; 19(6):e1011485. PubMed ID: 37384813
[TBL] [Abstract][Full Text] [Related]
19. Intranasal immunization with an RBD-hemagglutinin fusion protein harnesses preexisting immunity to enhance antigen-specific responses.
Kawai A; Tokunoh N; Kawahara E; Tamiya S; Okamura S; Ono C; Anindita J; Tanaka H; Akita H; Yamasaki S; Kunisawa J; Okamoto T; Matsuura Y; Hirai T; Yoshioka Y
J Clin Invest; 2023 Dec; 133(23):. PubMed ID: 38038133
[TBL] [Abstract][Full Text] [Related]
20. A modified porous silicon microparticle potentiates protective systemic and mucosal immunity for SARS-CoV-2 subunit vaccine.
Adam A; Shi Q; Wang B; Zou J; Mai J; Osman SR; Wu W; Xie X; Aguilar PV; Bao X; Shi PY; Shen H; Wang T
Transl Res; 2022 Nov; 249():13-27. PubMed ID: 35688318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
